Explore more publications!

Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

Press releases published on January 8, 2026

Telos Corporation Renews $5.4M Cyber GRC Engagement with Leading Global Technology Company
SEO As Easy As Using a Toaster: Tech Startup Replaces Complex Analytics with Simplicity and a Ranking Guarantee
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders
ORYZON to Participate in Upcoming Events in January
Coralogix Announces U.S. Department of Education Sponsorship for FedRAMP® Authorization
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
AirJoule Technologies Begins Net Zero Innovation Hub for Data Centers Program and Advances Commercial Deployment with Google, Microsoft, and Industry Leaders
Collegium Provides 2026 Financial Guidance and Business Update
Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
SiTime to Present at the Needham Growth Conference on January 13, 2026
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621
CareCloud Brings Wellsoft to Urgent Care with Affinity Deal, Targeting a Larger Nationwide Market Opportunity

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions